These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37971881)

  • 1. Efficient pulmonary lymphatic drainage is necessary for inflammation resolution in ARDS.
    Zhang PH; Zhang WW; Wang SS; Wu CH; Ding YD; Wu XY; Smith FG; Hao Y; Jin SW
    JCI Insight; 2024 Jan; 9(1):. PubMed ID: 37971881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor c/vascular endothelial growth factor receptor 3 signaling regulates chemokine gradients and lymphocyte migration from tissues to lymphatics.
    Iwami D; Brinkman CC; Bromberg JS
    Transplantation; 2015 Apr; 99(4):668-77. PubMed ID: 25606800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The VEGF-C/VEGFR3 signaling pathway contributes to resolving chronic skin inflammation by activating lymphatic vessel function.
    Hagura A; Asai J; Maruyama K; Takenaka H; Kinoshita S; Katoh N
    J Dermatol Sci; 2014 Feb; 73(2):135-41. PubMed ID: 24252749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary lymphangiectasia resulting from vascular endothelial growth factor-C overexpression during a critical period.
    Yao LC; Testini C; Tvorogov D; Anisimov A; Vargas SO; Baluk P; Pytowski B; Claesson-Welsh L; Alitalo K; McDonald DM
    Circ Res; 2014 Feb; 114(5):806-22. PubMed ID: 24429550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anatomy and function of the lymphatic vessels in the parietal pleura and their plasticity under inflammation in mice.
    Ren Y; Okazaki T; Ngamsnae P; Hashimoto H; Ikeda R; Honkura Y; Suzuki J; Izumi SI
    Microvasc Res; 2023 Jul; 148():104546. PubMed ID: 37230165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VEGF-C and VEGF-C156S in the pro-lymphangiogenic growth factor therapy of lymphedema: a large animal study.
    Visuri MT; Honkonen KM; Hartiala P; Tervala TV; Halonen PJ; Junkkari H; Knuutinen N; Ylä-Herttuala S; Alitalo KK; Saarikko AM
    Angiogenesis; 2015 Jul; 18(3):313-26. PubMed ID: 26018927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of VEGF ligands and receptors in prostate cancer.
    Woollard DJ; Opeskin K; Coso S; Wu D; Baldwin ME; Williams ED
    Prostate; 2013 May; 73(6):563-72. PubMed ID: 23038639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of lymphangiogenesis and lymphatic drainage via vascular endothelial growth factor receptor 3 blockade increases the severity of inflammation in a mouse model of chronic inflammatory arthritis.
    Guo R; Zhou Q; Proulx ST; Wood R; Ji RC; Ritchlin CT; Pytowski B; Zhu Z; Wang YJ; Schwarz EM; Xing L
    Arthritis Rheum; 2009 Sep; 60(9):2666-76. PubMed ID: 19714652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation.
    Baluk P; Tammela T; Ator E; Lyubynska N; Achen MG; Hicklin DJ; Jeltsch M; Petrova TV; Pytowski B; Stacker SA; Ylä-Herttuala S; Jackson DG; Alitalo K; McDonald DM
    J Clin Invest; 2005 Feb; 115(2):247-57. PubMed ID: 15668734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation and Lymphatic Function.
    Schwager S; Detmar M
    Front Immunol; 2019; 10():308. PubMed ID: 30863410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the VEGFR-3 pathway by VEGF-C attenuates UVB-induced edema formation and skin inflammation by promoting lymphangiogenesis.
    Kajiya K; Sawane M; Huggenberger R; Detmar M
    J Invest Dermatol; 2009 May; 129(5):1292-8. PubMed ID: 19005491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
    Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
    Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADSCs stimulated by VEGF-C alleviate intestinal inflammation via dual mechanisms of enhancing lymphatic drainage by a VEGF-C/VEGFR-3-dependent mechanism and inhibiting the NF-κB pathway by the secretome.
    Zhang L; Ye C; Li P; Li C; Shu W; Zhao Y; Wang X
    Stem Cell Res Ther; 2022 Sep; 13(1):448. PubMed ID: 36064450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Receptor Binding and Regulatory Mechanisms for the Lymphangiogenic Growth Factors Vascular Endothelial Growth Factor (VEGF)-C and -D.
    Davydova N; Harris NC; Roufail S; Paquet-Fifield S; Ishaq M; Streltsov VA; Williams SP; Karnezis T; Stacker SA; Achen MG
    J Biol Chem; 2016 Dec; 291(53):27265-27278. PubMed ID: 27852824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VEGF-C/VEGFR-3 signalling in macrophages ameliorates acute lung injury.
    Yamashita M; Niisato M; Kawasaki Y; Karaman S; Robciuc MR; Shibata Y; Ishida Y; Nishio R; Masuda T; Sugai T; Ono M; Tuder RM; Alitalo K; Yamauchi K
    Eur Respir J; 2022 Apr; 59(4):. PubMed ID: 34446463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor-C stimulates the lymphatic pump by a VEGF receptor-3-dependent mechanism.
    Breslin JW; Gaudreault N; Watson KD; Reynoso R; Yuan SY; Wu MH
    Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H709-18. PubMed ID: 17400713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An important role of lymphatic vessel activation in limiting acute inflammation.
    Huggenberger R; Siddiqui SS; Brander D; Ullmann S; Zimmermann K; Antsiferova M; Werner S; Alitalo K; Detmar M
    Blood; 2011 Apr; 117(17):4667-78. PubMed ID: 21364190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular control of lymphatic metastasis.
    Achen MG; Stacker SA
    Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype.
    Issa A; Le TX; Shoushtari AN; Shields JD; Swartz MA
    Cancer Res; 2009 Jan; 69(1):349-57. PubMed ID: 19118020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3.
    Kodera Y; Katanasaka Y; Kitamura Y; Tsuda H; Nishio K; Tamura T; Koizumi F
    Breast Cancer Res; 2011 Jun; 13(3):R66. PubMed ID: 21693010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.